SUBSCRIBE
SUBSCRIBE

bioAffinity Technologies, Inc.

IN THE PRESS
Press Releases
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
November 14, 2024
 · 
11 min read
Press Releases
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
November 4, 2024
 · 
5 min read
Press Releases
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
October 30, 2024
 · 
4 min read
Press Releases
bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
October 17, 2024
 · 
5 min read
Press Releases
bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer
October 10, 2024
 · 
4 min read
Press Releases
bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test
October 9, 2024
 · 
6 min read
Press Releases
Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
September 18, 2024
 · 
8 min read
Lone Star Bio
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
June 12, 2024
 · 
6 min read
Business
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
May 15, 2024
 · 
10 min read
Lone Star Bio
bioAffinity Technologies News Update - May 02, 2024
May 2, 2024
 · 
5 min read
Load More
JOBS